Lori Anne Kunkel's Net Worth

$9.72 Million

Estimate Recalculated Nov 5, 2024 07:08PM EST

Who is Lori Anne Kunkel

Lori Anne Kunkel has an estimated net worth of $9.72 Million. This is based on reported shares across multiple companies, which include Nurix Therapeutics, Inc., Loxo Oncology, Inc., CURIS INC, Tocagen Inc, Oric Pharmaceuticals, Inc., PHARMACYCLICS INC, and Enliven Therapeutics, Inc..

SEC CIK

Lori Anne Kunkel's CIK is 0001536368

Past Insider Trading and Trends

2018 was Lori Anne Kunkel's most active year for acquiring shares with 7 total transactions. Lori Anne Kunkel's most active month to acquire stocks was the month of May. 2018 was Lori Anne Kunkel's most active year for disposing of shares, totalling 15 transactions. Lori Anne Kunkel's most active month to dispose stocks was the month of May. 2018 saw Lori Anne Kunkel paying a total of $229,948.16 for 251,142 shares, this is the most they've acquired in one year. In 2019 Lori Anne Kunkel cashed out on 119,392 shares for a total of $24,594,701.44, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nurix Therapeutics, Inc.

Investor
Updated Jul 18, 2024
Jul 17
25.00KMay 20
25.00KMay 04
17.50KMay 05
17.50KMay 06
54.03K
Showing 6 results

Loxo Oncology, Inc.

Investor
Updated Feb 15, 2019
Feb 15
22.34KScheduledOct 01
37.92KScheduledJun 14 - Jun 15
8.75KJun 13
ScheduledApr 20
ScheduledNov 02
ScheduledAug 22
11.00KJun 22
7.81KJun 10
7.81KJul 28
26.84K
Showing 11 results

CURIS INC

Investor
Updated Jan 31, 2022
85.00KJan 31
33.00KJan 28
180.00KMar 02
ScheduledJan 23
180.00KJan 21
185.00KJan 22
120.00KFeb 28
25.00KNov 11
Showing 9 results

Tocagen Inc

Acting-Chief Medical Officer
Updated Oct 04, 2019
7.50KOct 04
20.00KMay 29
35.00KJan 11
20.00KJun 21
4.53KApr 12
Showing 6 results

Oric Pharmaceuticals, Inc.

Investor
Updated Jun 14, 2024
25.60KJun 12
Jun 03
20.50KJun 14
53.70KJun 17
16.63KJun 16
28.52KJun 09
Showing 7 results

PHARMACYCLICS INC

Chief Medical Officer
Updated May 01, 2013
Apr 30
Oct 31
300.00KDec 01
1.00K
Showing 4 results

Enliven Therapeutics, Inc.

Investor
Updated Apr 10, 2024
37.88KApr 08
45.93K
Showing 2 results